Literature DB >> 12364588

Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus.

Surendran Mahalingam1, Brett A Lidbury.   

Abstract

Subneutralizing concentrations of antibody may enhance virus infection by bringing the virus-antibody complex into contact with the cell surface Fc receptors; this interaction facilitates entry of virus into the cell and is referred to as antibody-dependent enhancement (ADE) of infection. Northern analysis of macrophage RNA demonstrated that ADE infection by the indigenous Australian alphavirus Ross River (RRV-ADE) ablated or diminished message for tumor necrosis factor alpha (TNF-alpha), nitric-oxide synthase 2 (NOS2), and IFN regulatory factor 1 (IRF-1), as well as for IFN-inducible protein 10 (IP-10) and IFN-beta; the transcription of a control gene was unaffected. Additionally, electrophoretic mobility-shift assay (EMSA) studies showed that transcription factor IFN-alpha-activated factor (AAF), IFN-stimulated gene factor 3 (ISGF3), and nuclear factor-kappaB (NF-kappaB) complex formation in macrophage nuclear extracts were specifically suppressed post-RRV-ADE infection, emphasizing the capacity for ADE infections to compromise antiviral responses at the transcriptional level. The suppression of antiviral transcription factor complexes was shown to depend on replicating virus and was not simply a result of general antibody-Fc-receptor interaction. Although only a minority of cells ( approximately 15%) were shown to be positive for RRV by immunostaining techniques post ADE, molecular (RT-PCR) analysis showed that unstained cells carried RRV-RNA, indicating a higher level of viral infectivity than previously suspected. Electron microscopy studies confirmed this observation. Furthermore, levels of cellular IL-10 protein were dramatically elevated in RRV-ADE cultures. This evidence demonstrates that RRV can potently disrupt the activation of specific antiviral pathways via ADE infection pathways, and may suggest a significant mechanism in the infection and pathogenesis of other ADE viruses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364588      PMCID: PMC129781          DOI: 10.1073/pnas.202415999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3.

Authors:  M Tone; M J Powell; Y Tone; S A Thompson; H Waldmann
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

2.  Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production.

Authors:  K D Yang; W T Yeh; M Y Yang; R F Chen; M F Shaio
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

3.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

6.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection.

Authors:  B A Lidbury; S Mahalingam
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice.

Authors:  B A Lidbury; C Simeonovic; G E Maxwell; I D Marshall; A J Hapel
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

9.  Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.

Authors:  T Suzuki; H Kono; N Hirose; M Okada; T Yamamoto; K Yamamoto; Z Honda
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

10.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

View more
  32 in total

1.  Inhibition of transcription and translation in Sindbis virus-infected cells.

Authors:  Rodion Gorchakov; Elena Frolova; Ilya Frolov
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice.

Authors:  Karen A Herd; Suresh Mahalingam; Ian M Mackay; Michael Nissen; Theo P Sloots; Robert W Tindle
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.

Authors:  Erin Mehlhop; Camilo Ansarah-Sobrinho; Syd Johnson; Michael Engle; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

Review 4.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

5.  Enterovirus 71 infection of monocytes with antibody-dependent enhancement.

Authors:  Shih-Min Wang; I-Chun Chen; Ling-Yao Su; Kao-Jean Huang; Huan-Yao Lei; Ching-Chuan Liu
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

6.  Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Kaitlyn M Dambach; Gina C Donofrio; Boonrat Tassaneetrithep; Mary A Marovich
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

7.  Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses.

Authors:  Reed S Shabman; Thomas E Morrison; Christopher Moore; Laura White; Mehul S Suthar; Linda Hueston; Nestor Rulli; Brett Lidbury; Jenny P-Y Ting; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Bonnie M Slike; Timothy H Burgess; Randall M Mason; Shuenn-Jue Wu; Peifang Sun; Kevin Porter; Irani Fianza Rudiman; Djoko Yuwono; Pilaipan Puthavathana; Mary A Marovich
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

9.  Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection.

Authors:  Hoang Truong Long; Martin L Hibberd; Tran Tinh Hien; Nguyen Minh Dung; Tran Van Ngoc; Jeremy Farrar; Bridget Wills; Cameron P Simmons
Journal:  J Infect Dis       Date:  2009-02-15       Impact factor: 5.226

Review 10.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.